Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Saiyaara: Rajesh Kumar revealed about the star cast of Saiyaara, said- Ahan Pandey, Anit Padda are arrogant stars..
Donald Trump dealt humiliating blow in brutal Satan South Park scene
How to get a personal loan in UAE: Limits, rates and everything you need to know
Animation Career: Jobs in animation are increasing! Make your creative skills your career, know how to choose the right institute..
England boss Sarina Wiegman must make crucial Euro 2025 final decision after clear message
